The ideal candidate for Semaglutide in NYC includes: Adults with a BMI of 30 or higher (classified as obese) Individuals with a BMI of 27+ with weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol People struggling with portion control, food cravings, or emotional eating Patients looking for a doctor-supervised, non-surgical weight loss solution Anyone seeking long-term, sustainable weight loss without extreme dieting or excessive exercise Dr
Semaglutide, as a GLP-1 RA, also slows gastric emptying, enhances glucose-dependent insulin secretion, reduces glucagon, and increases satiety through central appetite regulation
Able, C., Liao, B., Saffati, G., et al
The drug is transported back into the bloodstream, thereby reducing brain levels of the drug and attenuating its effects (172)